These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29272060)

  • 1. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.
    Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
    Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
    IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus: from innate sensing to adaptive immune responses.
    Brüggemann Y; Klöhn M; Wedemeyer H; Steinmann E
    Nat Rev Gastroenterol Hepatol; 2024 Oct; 21(10):710-725. PubMed ID: 39039260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Interplay between Host Innate Immunity and Hepatitis E Virus.
    Li Y; Qu C; Yu P; Ou X; Pan Q; Wang W
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the development of a hepatitis E vaccine.
    Kamili S
    Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E virus.
    Abravanel F; Lhomme S; Dubois M; Peron JM; Alric L; Kamar N; Izopet J
    Med Mal Infect; 2013 Jul; 43(7):263-70. PubMed ID: 23608595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of vaccination against hepatitis E.
    Safary A
    Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making the case for the development of a vaccination against hepatitis E virus.
    Haffar S; Bazerbachi F; Lake JR
    Liver Int; 2015 Feb; 35(2):311-6. PubMed ID: 24836400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis E vaccine].
    Li TC; Takeda N; Miyamura T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():548-53. PubMed ID: 15453382
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective immunity against HEV.
    Huang SJ; Liu XH; Zhang J; Ng MH
    Curr Opin Virol; 2014 Apr; 5():1-6. PubMed ID: 24835679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of hepatitis e virus infection.
    Wedemeyer H; Pischke S; Manns MP
    Gastroenterology; 2012 May; 142(6):1388-1397.e1. PubMed ID: 22537448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
    van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
    Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
    Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.
    Goel A; Aggarwal R
    Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1065-74. PubMed ID: 27148907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection.
    Kamili S; Spelbring J; Carson D; Krawczynski K
    J Infect Dis; 2004 Jan; 189(2):258-64. PubMed ID: 14722891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.